Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 28 (9) , 1341-1349
- https://doi.org/10.1097/qad.0000000000000254
Abstract
Objective: HIV-positive MSM are at increased risk of anal human papillomavirus (HPV) infection compared with men in the general population, and little is known about the natural history of anal HPV infection in this population. The objective of this study was to determine the incidence of and risk factors for anal type-specific HPV infection. Design: Prospective cohort study. Methods: HIV-positive MSM were evaluated for anal HPV DNA, lifestyle factors, and sexual risk behaviors every 6 months for at least 2 years. Results: The overall incidence rate of detectable type-specific anal HPV infection was 21.3 per 100 person-years [95% confidence interval (CI) 17.7–25.4] and was 13.3/100 person-years (10.5–16.6) for oncogenic HPV types. The most common incident infections were HPV 18 (3.7/100 person-years) and HPV 16 (3.5/100 person-years). An increased number of recent partners with whom the participant was the receptive partner [odds ratio (OR) 2.9 (1.6–5.1) 8+ partners vs. 0–1], an increased number of new partners in which the participant was the receptive partner [OR 1.03 (1.01–1.1) per partner], an increased number of new oral–anal contact partners in which the participant was the receptive partner [OR 1.1 (1.03–1.1) per partner], and the frequency of receptive anal intercourse [OR 1.1 (1.03–1.1) per act] all significantly increased the odds of incident HPV infection (P ≤ 0.05). Conclusion: HIV-positive MSM have a high incidence of oncogenic anal HPV infection. Recent receptive anal sexual behaviors, including receptive anal intercourse and receptive oral–anal contact, are the most important risk factors for incident anal HPV infection.Keywords
This publication has 26 references indexed in Scilit:
- Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North AmericaClinical Infectious Diseases, 2012
- End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of ageBritish Journal of Cancer, 2011
- Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with menBMC Infectious Diseases, 2011
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Anal cancers among HIV-infected persons: HAART is not slowing rising incidenceAIDS, 2010
- Human papillomavirus (HPV) prevalence and type distribution, and HPV‐associated cytological abnormalities in anal specimens from men infected with HIV who have sex with menJournal of Medical Virology, 2010
- Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual menSexually Transmitted Infections, 2009
- Asymptomatic Sexually Transmitted Infections in HIV-Infected Men Who Have Sex with Men: Prevalence, Incidence, Predictors, and Screening StrategiesAIDS Patient Care and STDs, 2008
- Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapyAIDS, 2008
- Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal CancerNew England Journal of Medicine, 1987